Avitas Wealth Management LLC Gilead Sciences, Inc. Transaction History

Avitas Wealth Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 26, 2021	SELL	$56.65 - $64.55 $1.86 Million - $2.11 Million	-32,749 Closed	0 $0
Q3 2020 Oct 06, 2020	BUY	$62.1 - $78.08 $725,079 - $911,662	11,676 Added 55.41%	32,749 $2.07 Million
Q2 2020 Jul 30, 2020	SELL	$72.34 - $84.0 $34,216 - $39,732	-473 Reduced 2.2%	21,073 $1.62 Million
Q1 2020 May 13, 2020	BUY	$62.63 - $80.22 $1.35 Million - $1.73 Million	21,546 New	21,546 $1.61 Million

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Avitas Wealth Management LLC, based on Form 13F filings with the SEC.

Stay updated on Avitas Wealth Management LLC with notifications on news.